Remedial Health, a health technology company offering inventory, software, data, and financing solutions to healthcare providers across Africa, was named among the World’s Top HealthTech Companies by TIME Magazine and Statista. This recognition honors the company’s innovation and impact within the global healthcare sector. The ranking, which is a first of its kind, celebrates the most pioneering and promising HealthTech companies worldwide. Remedial Health was recognized in the Health Information & Management sector, receiving a performance rating of Very High.
The list of the World’s Top HealthTech Companies includes 400 companies from over 25 countries, covering six market segments: AI & Data Analytics, Diagnostics, Health Information & Management, Medical Devices & Wearables, Prevention, and Telehealth & Treatment. The ranking was based on three main evaluation criteria: financial performance metrics, which assessed stability, growth potential, and operational efficiency; reputation analysis, which considered public perception through media coverage, blogs, forums, and social media, focusing on visibility and credibility; and online engagement, which measured website traffic and digital audience interaction over the past 24 months.
To qualify for inclusion, companies had to have functional technological health products, significant public visibility, and active operations within one or more of the six HealthTech categories.
“Being recognised by TIME as one of the world’s top healthtech companies is a proud moment for our entire team and the communities we serve,” said Samuel Okwuada, CEO and co-founder of Remedial Health. “It reaffirms our mission to build the infrastructure for a more efficient, data-driven, and sustainable healthcare ecosystem in Africa, and we are only just getting started.”
Founded to address inefficiencies and fragmentation in Africa’s pharmaceutical ecosystem, Remedial Health now serves over 14,000 healthcare providers across all 36 states of Nigeria and the Federal Capital Territory (FCT). The company has partnered with over 300 manufacturers and distributors and, in just three years, has financed more than $40 million worth of medicines. This has allowed healthcare providers to access genuine and affordable products more efficiently, thus supporting better health outcomes for communities across the country.
